Amgen Inc. buy Royal Bank of Canada
Start price
15.01.26
/
50%
€284.25
Target price
15.01.27
€287.83
Performance (%)
12.98%
Price
10:12
€317.95
Summary
This prediction is currently active. The prediction currently has a performance of 12.98%. Dividends of €5.04 are taken into consideration when calculating the performance. This prediction currently runs until 15.01.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | 3.953% | 3.953% |
| iShares Core DAX® | 0.365% | -0.242% |
| iShares Nasdaq 100 | 2.592% | 1.795% |
| iShares Nikkei 225® | 1.801% | 7.119% |
| iShares S&P 500 | 1.205% | 0.930% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Amgen Inc. diskutieren
Amgen (NASDAQ:AMGN) had its price target raised by analysts at Royal Bank Of Canada from $330.00 to $335.00. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat